Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001709738-26-000007

Business Development Director sold 13,720 shares at $0.80 ($10,976)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Christianson Mark Business Development Director 2026-03-10 Sale −11,611 $0.80 $9,289 217,309 D: show line 1 in the form
Christianson Mark Business Development Director 2026-03-11 Sale −2,109 $0.80 $1,687 215,200 D: show line 2 in the form
Open-market sales · 13,720 sh · avg $0.80 · $10,976
Loading xslF345X05/primary_doc.xml…